SHAREHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2017

SHAREHOLDERS' EQUITY

Schedule of stock options

	Number of		Weighted average exercise price	Weighted average remaining contractual life	Aggregate intrinsic value
	options		$	(years)	$
Options outstanding at January 1, 2017	1,689,555		4.02	6.06	(*	)
Options granted	113,107		4.60
Options exercised	(32,910	)	3.61
Options forfeited	(5,178	)	3.96
Options outstanding at end of the period	1,764,574		4.06	5.65	214
Options vested at end of the period	1,220,705		4.17	4.39	80

(*) Represent amount less than $1.

Schedule of the assumptions used to estimate the fair values of the options granted

	Nine months ended
	September 30, 2017
Risk-free interest rate	2.07	%
Volatility	86.4	%
Expected life (in years)	5.87
Dividend yield	0	%

Schedule of total compensation cost related to all of the Company's equity-based awards

	Nine months ended September 30,
	2017		2016
	Unaudited
Research and development	$	153	$	90
Sales and marketing	48		5
General and administrative	519		504
	$	720	$	599